These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Genetics of pigmentation and melanoma predisposition. Pho LN; Leachman SA G Ital Dermatol Venereol; 2010 Feb; 145(1):37-45. PubMed ID: 20197744 [TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms in DNA repair and oxidative stress pathways associated with malignant melanoma susceptibility. Ibarrola-Villava M; Peña-Chilet M; Fernandez LP; Aviles JA; Mayor M; Martin-Gonzalez M; Gomez-Fernandez C; Casado B; Lazaro P; Lluch A; Benitez J; Lozoya R; Boldo E; Pizarro A; Martinez-Cadenas C; Ribas G Eur J Cancer; 2011 Nov; 47(17):2618-25. PubMed ID: 21641795 [TBL] [Abstract][Full Text] [Related]
6. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953 [TBL] [Abstract][Full Text] [Related]
7. Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma. Mössner R; Anders N; König IR; Krüger U; Schmidt D; Berking C; Ziegler A; Brockmöller J; Kaiser R; Volkenandt M; Westphal GA; Reich K Arch Dermatol Res; 2007 Jan; 298(8):371-9. PubMed ID: 17072629 [TBL] [Abstract][Full Text] [Related]
8. Genetic analysis of three important genes in pigmentation and melanoma susceptibility: CDKN2A, MC1R and HERC2/OCA2. Ibarrola-Villava M; Fernandez LP; Pita G; Bravo J; Floristan U; Sendagorta E; Feito M; Avilés JA; Martin-Gonzalez M; Lázaro P; Benítez J; Ribas G Exp Dermatol; 2010 Sep; 19(9):836-44. PubMed ID: 20629734 [TBL] [Abstract][Full Text] [Related]
9. The contribution of melanocortin 1 receptor gene polymorphisms and the agouti signalling protein gene 8818A>G polymorphism to cutaneous melanoma and basal cell carcinoma in a Polish population. Brudnik U; Branicki W; Wojas-Pelc A; Kanas P Exp Dermatol; 2009 Feb; 18(2):167-74. PubMed ID: 18637131 [TBL] [Abstract][Full Text] [Related]
10. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study. Fargnoli MC; Altobelli E; Keller G; Chimenti S; Höfler H; Peris K Melanoma Res; 2006 Apr; 16(2):175-82. PubMed ID: 16567973 [TBL] [Abstract][Full Text] [Related]
11. Increased risk of developing cutaneous malignant melanoma is associated with variation in pigmentation genes and VDR, and may involve epistatic effects. Kosiniak-Kamysz A; Marczakiewicz-Lustig A; Marcińska M; Skowron M; Wojas-Pelc A; Pośpiech E; Branicki W Melanoma Res; 2014 Aug; 24(4):388-96. PubMed ID: 24926819 [TBL] [Abstract][Full Text] [Related]
12. Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians. Nan H; Kraft P; Hunter DJ; Han J Int J Cancer; 2009 Aug; 125(4):909-17. PubMed ID: 19384953 [TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of the neuronal and inducible nitric oxide synthase genes and the risk of cutaneous melanoma: a case-control study. Li C; Hu Z; Liu Z; Wang LE; Gershenwald JE; Lee JE; Prieto VG; Duvic M; Grimm EA; Wei Q Cancer; 2007 Apr; 109(8):1570-8. PubMed ID: 17328085 [TBL] [Abstract][Full Text] [Related]
14. Common variants on 1p36 and 1q42 are associated with cutaneous basal cell carcinoma but not with melanoma or pigmentation traits. Stacey SN; Gudbjartsson DF; Sulem P; Bergthorsson JT; Kumar R; Thorleifsson G; Sigurdsson A; Jakobsdottir M; Sigurgeirsson B; Benediktsdottir KR; Thorisdottir K; Ragnarsson R; Scherer D; Rudnai P; Gurzau E; Koppova K; Höiom V; Botella-Estrada R; Soriano V; Juberías P; Grasa M; Carapeto FJ; Tabuenca P; Gilaberte Y; Gudmundsson J; Thorlacius S; Helgason A; Thorlacius T; Jonasdottir A; Blondal T; Gudjonsson SA; Jonsson GF; Saemundsdottir J; Kristjansson K; Bjornsdottir G; Sveinsdottir SG; Mouy M; Geller F; Nagore E; Mayordomo JI; Hansson J; Rafnar T; Kong A; Olafsson JH; Thorsteinsdottir U; Stefansson K Nat Genet; 2008 Nov; 40(11):1313-8. PubMed ID: 18849993 [TBL] [Abstract][Full Text] [Related]
15. Case-control study to identify melanoma risk factors in the Belgian population: the significance of clinical examination. Nijsten T; Leys C; Verbruggen K; Verlinden V; Drieghe J; Stas M; Lambert J; DeGreef H; Garmyn M J Eur Acad Dermatol Venereol; 2005 May; 19(3):332-9. PubMed ID: 15857460 [TBL] [Abstract][Full Text] [Related]
16. Variants of the MATP/SLC45A2 gene are protective for melanoma in the French population. Guedj M; Bourillon A; Combadières C; Rodero M; Dieudé P; Descamps V; Dupin N; Wolkenstein P; Aegerter P; Lebbe C; Basset-Seguin N; Prum B; Saiag P; Grandchamp B; Soufir N; Hum Mutat; 2008 Sep; 29(9):1154-60. PubMed ID: 18683857 [TBL] [Abstract][Full Text] [Related]
17. Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach. Kanetsky PA; Ge F; Najarian D; Swoyer J; Panossian S; Schuchter L; Holmes R; Guerry D; Rebbeck TR Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):808-19. PubMed ID: 15159314 [TBL] [Abstract][Full Text] [Related]
19. Genes involved in the WNT and vesicular trafficking pathways are associated with melanoma predisposition. Ibarrola-Villava M; Kumar R; Nagore E; Benfodda M; Guedj M; Gazal S; Hu HH; Guan J; Rachkonda PS; Descamps V; Basset-Seguin N; Bensussan A; Bagot M; Saiag P; Schadendorf D; Martin-Gonzalez M; Mayor M; Grandchamp B; Ribas G; Soufir N Int J Cancer; 2015 May; 136(9):2109-19. PubMed ID: 25303718 [TBL] [Abstract][Full Text] [Related]